Amedisys Inc. buy Credit Suisse Group AG
Start price
28.02.23
/
50%
€85.50
Target price
28.02.24
€108.15
Performance (%)
-0.58%
End price
29.02.24
€85.00
Summary
This prediction ended on 29.02.24 with a price of €85.00. During the runtime of the prediction for Amedisys Inc. the price only changed by -0.58%. Credit_Suisse_Group_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Amedisys Inc. | - | - | - | - |
| iShares Core DAX® | -1.862% | 0.670% | 0.920% | 51.849% |
| iShares Nasdaq 100 | -3.322% | 4.989% | 33.716% | 86.850% |
| iShares Nikkei 225® | -2.299% | 6.129% | 52.955% | 63.321% |
| iShares S&P 500 | -1.313% | 3.399% | 24.674% | 66.112% |
Comments by Credit_Suisse_Group_ for this prediction
In the thread Amedisys Inc. diskutieren
Amedisys, Inc. (NASDAQ: AMED) had its "outperform" rating re-affirmed by analysts at Credit Suisse Group AG. They now have a $115.00 price target on the stock.
Ratings data for AMED provided by MarketBeat
In the thread Trading Amedisys Inc.
Die von Credit_Suisse_Group_ gewählte maximale Laufzeit wurde überschritten